BDBM50062804 ((S)-1-{2-[2-(4-Carbamimidoyl-phenyl)-acetylamino]-acetyl}-4-carboxymethyl-3-oxo-piperazin-2-yl)-acetic acid::CHEMBL146031

SMILES NC(=N)c1ccc(CC(=O)NCC(=O)N2CCN(CC(O)=O)C(=O)[C@@H]2CC(O)=O)cc1

InChI Key InChIKey=KMXIJCGQJFYWTC-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50062804   

TargetIntegrin alpha-IIb/beta-3(Human)
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50062804(((S)-1-{2-[2-(4-Carbamimidoyl-phenyl)-acetylamino]...)
Affinity DataIC50: 8.10nMAssay Description:Ability to inhibit binding of biotin-labeled human fibrinogen to immobilized fibrinogen receptor purified from human erythroleukemia (HEL) cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50062804(((S)-1-{2-[2-(4-Carbamimidoyl-phenyl)-acetylamino]...)
Affinity DataIC50: 1.20E+3nMAssay Description:Concentration required to inhibit adenosine diphosphate (ADP) induced aggregation of human platelets by 50% in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50062804(((S)-1-{2-[2-(4-Carbamimidoyl-phenyl)-acetylamino]...)
Affinity DataIC50: 1.60E+3nMAssay Description:Concentration required to inhibit adenosine diphosphate (ADP) induced aggregation of guinea pig platelets by 50% in vitroMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed